Study of Ceritinib in Patients With Unresectable Melanoma
about
Study of Ceritinib in Patients With Unresectable Melanoma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study of Ceritinib in Patients With Unresectable Melanoma
@en
type
label
Study of Ceritinib in Patients With Unresectable Melanoma
@en
prefLabel
Study of Ceritinib in Patients With Unresectable Melanoma
@en
P1050
P1476
Phase 2 Study of Ceritinib in Patients With Unresectable Melanoma
@en
P3098
NCT03501368
P4844
P580
2018-06-18T00:00:00Z
P582
2021-06-01T00:00:00Z